Special Issue "Research and Development of Novel MOFs (Metal-Organic Framework) Drug Formulations"
Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 3801
Interests: drug delivery; MOF; chemotherapeutics agents; MRI; photodynamic therapy
Special Issues, Collections and Topics in MDPI journals
Metal–organic frameworks (MOFs) are typical coordination polymers constructed by metal ions/clusters and multitopic organic ligands. Compared with traditional porous materials, MOFs have the advantages of significant porosity, large specific surface area, adjustable chemical composition, and structure tailorability; these unique features make them a promising candidate for controlled drug delivery. This Special Issue aims to collect the recent advances in the development of MOFs for drug delivery, in particular focusing on their ability to deliver various drugs and their release mechanisms, as well as the in vivo and in vitro biological evaluation.
Jianqiang Liu obtained his PhD degree from Northwest University, China, in 2010. After he joined the School of Pharmacy at the Guangdong Medical University as an Assistant Professor in 2012. He was promoted to a Full Professor in 2018. From 2012 to 2019, he worked as a senior visiting scholar at Tsinghua University, Sun Yat-sen Medical University in Taiwan and Yamagata University in Japan. His current research interest focuses on the development of functional materials including metal–organic frameworks (MOFs) and porous organic polymers (POPs) for energy, biology, and environment-related applications.
Dr. Jian-Qiang Liu
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- drug delivery
- tumor therapy
- cell membrane
- oxygen species (ROS)
- antibacterial therapy